Showing results (231-240 of 252) with videos related to
Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup studyA de Gramont, J F Bosset, C Milan, et al.Journal of Pharmaceutical Sciences|February 15, 2001
New bis(SATE) prodrug of AZT 5'-monophosphate: in vitro anti-HIV activity, stability, and potential oral absorptionM Shafiee, S Deferme, A L Villard, et al.Journal of Medicinal Chemistry|May 1, 1989
Synthesis, DNA binding, and biological evaluation of synthetic precursors and novel analogues of netropsinF Debart, C Periguad, G Gosselin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Epirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer GroupJ A Wils, J M Bliss, M Marty, et al.Annals of Human Genetics|January 18, 2007
The impact of ACE genotype on serum ACE activity in a black South African male populationJ R Payne, S S Dhamrait, P Gohlke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimenT André, M A Bensmaine, C Louvet, et al.European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancerP Rougier, B Paillot, A LaPlanche, et al.Antiviral Chemistry & Chemotherapy|August 31, 2001
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replicationL Placidi, A Faraj, A G Loi, et al.Social Work in Public Health|February 17, 2022
Social Work's Response during the COVID-19 Pandemic: A Systematic Literature Review-Balancing Telemedicine with Social Work Self-Care during A PandemicMichael A Sullivan-Tibbs, Catovia B Rayner, David L Crouch, et al.Nature Communications|May 13, 2024
Tailoring amorphous boron nitride for high-performance two-dimensional electronicsCindy Y Chen, Zheng Sun, Riccardo Torsi, et al.Pageof 26